Crestline Management »

Cytokinetics shares owned by Crestline Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Crestline Management from 13F filings

Historical chart of Crestline Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Crestline Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Crestline Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.9M 35k 83.49
2023-09-30 $589k 20k 29.46

More positions owned by Crestline Management

Denali Therapeutics (DNLI)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Macy's (M)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Energy Transfer Com Ut Ltd Ptn (ET)
First Industrial Realty Trust (FR)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Arcosa (ACA)
NiSource (NI)
Bausch Health Companies (BHC)
PPL Corporation (PPL)
American Intl Group Com New (AIG)
Allstate Corporation (ALL)
Algonquin Power & Utilities equs (AQN)
Sana Biotechnology (SANA)

View all positions for Crestline Management

Top funds holding Cytokinetics

Vanguard Group
Wellington Management Company
Caption Management
T. Rowe Price Associates
Henderson Group
Boxer Capital
Citadel Advisors
Partner Fund Management
Logos Global Management
Lord, Abbett & Co
Millennium Management
Artal Group
Barclays
Gts Securities
Goldman Sachs Group

View all funds holding Cytokinetics